Literature DB >> 11177767

Pathogenesis of calcium pyrophosphate crystal deposition disease.

A K Rosenthal1.   

Abstract

Calcium pyrophosphate dihydrate deposition (CPPDD) disease is an increasingly common form of arthritis affecting the elderly. It is characterized by the formation of CPPD crystals in articular cartilage and usually results in severe cartilage destruction with loss of joint function. This article discusses our understanding of how and why these crystals form, highlighting recent developments in the field.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11177767     DOI： 10.1007/s11926-001-0046-x

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  37 in total

1.  Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.

Authors:  L J Andrew; V Brancolini; L S de la Pena; M Devoto; F Caeiro; R Marchegiani; A Reginato; A Gaucher; P Netter; P Gillet; D Loeuille; D J Prockop; A Carr; B F Wordsworth; M Lathrop; S Butcher; E Considine; K Everts; A Nicod; S Walsh; C J Williams
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

2.  Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization.

Authors:  K Johnson; A Jung; A Murphy; A Andreyev; J Dykens; R Terkeltaub
Journal:  Arthritis Rheum       Date:  2000-07

Review 3.  Molecular biology of matrix vesicles.

Authors:  H C Anderson
Journal:  Clin Orthop Relat Res       Date:  1995-05       Impact factor: 4.176

4.  Transduction mechanisms of porcine chondrocyte inorganic pyrophosphate elaboration.

Authors:  L M Ryan; I V Kurup; H S Cheung
Journal:  Arthritis Rheum       Date:  1999-03

Review 5.  Latent transforming growth factor-beta: structural features and mechanisms of activation.

Authors:  J S Munger; J G Harpel; P E Gleizes; R Mazzieri; I Nunes; D B Rifkin
Journal:  Kidney Int       Date:  1997-05       Impact factor: 10.612

6.  Role of the mouse ank gene in control of tissue calcification and arthritis.

Authors:  A M Ho; M D Johnson; D M Kingsley
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

7.  Stimulation of cartilage inorganic pyrophosphate elaboration by ascorbate.

Authors:  L M Ryan; I Kurup; H S Cheung
Journal:  Matrix       Date:  1991-08

8.  Articular cartilage vesicles generate calcium pyrophosphate dihydrate-like crystals in vitro.

Authors:  B A Derfus; J W Rachow; N S Mandel; A L Boskey; M Buday; V M Kushnaryov; L M Ryan
Journal:  Arthritis Rheum       Date:  1992-02

9.  Causal link between nucleotide pyrophosphohydrolase overactivity and increased intracellular inorganic pyrophosphate generation demonstrated by transfection of cultured fibroblasts and osteoblasts with plasma cell membrane glycoprotein-1. Relevance to calcium pyrophosphate dihydrate deposition disease.

Authors:  R Terkeltaub; M Rosenbach; F Fong; J Goding
Journal:  Arthritis Rheum       Date:  1994-06

10.  Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes.

Authors:  D Aeschlimann; A Wetterwald; H Fleisch; M Paulsson
Journal:  J Cell Biol       Date:  1993-03       Impact factor: 10.539
View more
  4 in total

1.  Treatment and management of pseudogout: insights for the clinician.

Authors:  Paul Macmullan; Geraldine McCarthy
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-04       Impact factor: 5.346

2.  Identification of monoclinic calcium pyrophosphate dihydrate and hydroxyapatite in human sclera using Raman microspectroscopy.

Authors:  Ko-Hua Chen; Mei-Jane Li; Wen-Ting Cheng; Tonci Balic-Zunic; Shan-Yang Lin
Journal:  Int J Exp Pathol       Date:  2009-02       Impact factor: 1.925

Review 3.  Nonpharmacologic and pharmacologic management of CPP crystal arthritis and BCP arthropathy and periarticular syndromes.

Authors:  Ann K Rosenthal; Lawrence M Ryan
Journal:  Rheum Dis Clin North Am       Date:  2014-02-19       Impact factor: 2.670

Review 4.  The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease.

Authors:  Alberto Altomare; Addolorata Corrado; Nicola Maruotti; Daniela Cici; Francesco Paolo Cantatore
Journal:  Mol Biol Rep       Date:  2021-06-01       Impact factor: 2.316
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.